Test ID WGSEQ Gamma-Globin Full Gene Sequencing, Varies
Necessary Information
A complete patient history is strongly encouraged.
Specimen Required
Submit only 1 of the following specimens:
Specimen Type: Whole blood
Container/Tube:
Preferred: Lavender top (EDTA)
Acceptable: Yellow top (ACD)
Specimen Volume: 4 mL
Collection Instructions:
1. Invert several times to mix blood.
2. Send whole blood specimen in the original tube. Do not aliquot.
Specimen Stability Information: Refrigerate 30 days(preferred)/Ambient 14 days
Specimen Type: Extracted DNA from whole blood
Container/Tube: 1.5 to 2 mL tube
Specimen Volume: Entire specimen
Collection Instructions: Label specimen as extracted DNA from blood and provide indication of volume and concentration of the DNA
Specimen Stability Information: Frozen (preferred)/Refrigerate/Ambient
Forms
1. New York Clients-Informed consent is required. Document on the request form or electronic order that a copy is on file. The following documents are available:
-Informed Consent for Genetic Testing (T576)
-Informed Consent for Genetic Testing-Spanish (T826)
2. Thalassemia/Hemoglobinopathy Patient Information (T358)
3. If not ordering electronically, complete, print, and send a Benign Hematology Test Request (T755) with the specimen.
Useful For
An adjunct in the interpretation of hemoglobin electrophoresis results
Evaluation for suspected gamma variants or nondeletional hereditary persistence of fetal hemoglobin
Assessment of unstable gamma chain variants when other tests for causes of hemolysis are unrevealing
Genetics Test Information
The beta-like hemoglobins include the epsilon, gamma, beta, and delta globins, whose genes are present on chromosome 11 in a linked cluster (ie, the beta globin complex). The gamma genes, HBG1 (Ay) and HBG2 (Gy), contain 3 exonic coding regions and 2 intronic intervening sequences (IVS). The genes produce gamma globin chains that form tetramers with alpha globin chains to create fetal hemoglobin (Hb F). HBG1 and HBG2 differ only in which amino acid is located at position 136 (alanine or glycine). The resultant proteins are named A-gamma and G-gamma, respectively. Although G-gamma is predominant at birth, this gradually reverses during the first year of life to become the normal adult G-gamma/A-gamma ratio, which is 2:3. Some people maintain an increased G-gamma:A-gamma ratio throughout life, which has been linked to certain alterations in either gene. Additionally, some alterations in the promoter regions of the gamma globin genes are known to cause a form of hereditary persistence of fetal hemoglobin (HPFH), which is characterized by a significant but harmless elevation of Hb F into adulthood. If coinherited with sickle cell disease, HPFH has a strong modulating effect on the condition and appears to protect against some, but not all, of its complications. Some gamma genetic variations result in gamma chain hemoglobin variants, most of which are clinically insignificant; however, an incompletely studied subset causes neonatal disorders, such as hemolytic anemia, cyanosis, and methemoglobinemia.
Highlights
This test should be used as an adjunct to abnormal results detected by hemoglobin electrophoresis testing. It will assist with:
-Diagnosis of nondeletional hereditary persistence of fetal hemoglobin (HPFH)
-Identification of abnormal gamma chain variants (eg, unstable, high- or low-oxygen affinity, or M hemoglobins)
-Predicting the severity of a coinherited sickling disorder
-Evaluation of unexplained neonatal anemia, cyanosis, or hyperbilirubinemia
Special Instructions
Method Name
Polymerase Chain Reaction (PCR) Amplification/Sanger Sequence Analysis
Reporting Name
Gamma Globin Full Gene SequencingSpecimen Type
VariesSpecimen Minimum Volume
Blood: 1 mL; Extracted DNA: 50 mcL at 50 ng/mcL concentration
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Varies | Varies |
Reference Values
An interpretive report will be provided.
Day(s) Performed
Monday through Friday
Report Available
10 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
81479-Unlisted molecular
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
WGSEQ | Gamma Globin Full Gene Sequencing | 95795-1 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
46952 | Gamma Globin Gene Sequencing Result | 50397-9 |
46953 | Gamma Globin Interpretation | 59466-3 |